Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Healthcare Medical Devices
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp > Connections with the MNC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(92)
•••
Comment by Insightful1on Sep 04, 2021 11:16am
92 Views
Post# 33814389

RE:RE:RE:RE:RE:Connections with the MNC

RE:RE:RE:RE:RE:Connections with the MNC

I am just curious from 2017 to 2021 would have you thought of DermTech as the leader??
I understand your frustration but to secure large scale business in the MedTech space is not as simple a task as a lot of poster assume. DermTech has had a great run but they burn money at a substantial rate and I have always maintained they cannot hold a market capitalization of over $1,2 Billion (my first post on DermTech)  and the marketplace is recognizing this by looking at the shareprice. 

I am hoping when Sylvain gets out to tell the MedX story it will attract a lot of new shareholders.

Shout out to Dunworkin for posting Hennigar's Insider buying. It has been a while since we have had insider's buying . I think all the Directors now have shares that they paid for so it is a start.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities